Basic Information
Basic information for AC090114.2-201-13aa-2
Peptide Name AC090114.2-201-13aa-2
Genome Position chr7:128526726-128526764[-]
Species Human
Peptide Sequence MVAGACSPSYSGG
Peptide Length 13
Unique No (KDM4A-AS1-201-13aa,AC093426.1-201-13aa-1,AC068473.3-201-13aa,AC022150.2-201-13aa,AC122688.4-201-13aa,AL022311.1-201-13aa-7,LINC02540-202-13aa-3,KDM4A-AS1-206-13aa-1,AC019294.2-213-13aa-1,AC021092.1-203-13aa-2,LINC02082-202-13aa)
Grand Average of Hydropathicity 0.4385
Relative Molecular Mass 1402.5
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000273270;AC090114.2
Transcript ID/Name ENST00000608477;AC090114.2-201
Transcript Length 7054
Coding Ability 0.4481
DNA Sequence Corresponding to Peptide ATGGTGGCGGGCGCCTGTAGTCCCAGCTACTCGGGAGGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :